BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27494126)

  • 1. Smith-Magenis Syndrome and Social Security Administration's Compassionate Allowances Initiative: An Evaluative Review of the Literature.
    Burke SL; Maramaldi P
    Intellect Dev Disabil; 2016 Aug; 54(4):273-84. PubMed ID: 27494126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Social Security Administration's Compassionate Allowances Initiative: Condition Spotlight on Rubinstein-Taybi Syndrome.
    Burke SL; Maramaldi P
    Health Soc Work; 2017 Feb; 42(1):e32-e43. PubMed ID: 28395077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability in Clinical and Anatomical Manifestation of Velocardiofacial Syndrome Presents Diagnostic and Policy Uncertainty.
    Burke S; Maramaldi P
    Fetal Pediatr Pathol; 2017 Feb; 36(1):33-41. PubMed ID: 27732116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nature of social preference and interactions in Smith-Magenis syndrome.
    Wilde L; Silva D; Oliver C
    Res Dev Disabil; 2013 Dec; 34(12):4355-65. PubMed ID: 24120292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurologic and developmental features of the Smith-Magenis syndrome (del 17p11.2).
    Gropman AL; Duncan WC; Smith AC
    Pediatr Neurol; 2006 May; 34(5):337-50. PubMed ID: 16647992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic difficulties in Smith-Magenis Syndrome (SMS) on the basis of own experience and literature data].
    Stembalska A; Jakubiak A; Śmigiel R
    Med Wieku Rozwoj; 2012; 16(2):138-43. PubMed ID: 22971658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in Smith-Magenis syndrome (del 17p11.2).
    Gropman AL; Elsea S; Duncan WC; Smith AC
    Curr Opin Neurol; 2007 Apr; 20(2):125-34. PubMed ID: 17351481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individuals with Smith-Magenis syndrome display profound neurodevelopmental behavioral deficiencies and exhibit food-related behaviors equivalent to Prader-Willi syndrome.
    Alaimo JT; Barton LV; Mullegama SV; Wills RD; Foster RH; Elsea SH
    Res Dev Disabil; 2015 Dec; 47():27-38. PubMed ID: 26323055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The behavioural phenotype of Smith-Magenis syndrome: evidence for a gene-environment interaction.
    Taylor L; Oliver C
    J Intellect Disabil Res; 2008 Oct; 52(10):830-41. PubMed ID: 18466291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epilepsy and chromosomal rearrangements in Smith-Magenis Syndrome [del(17)(p11.2p11.2)].
    Goldman AM; Potocki L; Walz K; Lynch JK; Glaze DG; Lupski JR; Noebels JL
    J Child Neurol; 2006 Feb; 21(2):93-8. PubMed ID: 16566870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in Social Motivation in Children with Smith-Magenis Syndrome and Down Syndrome.
    Wilde L; Mitchell A; Oliver C
    J Autism Dev Disord; 2016 Jun; 46(6):2148-2159. PubMed ID: 26983920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Social Security Administration's Disability Service Improvement process.
    Barnhart JA
    Soc Secur Bull; 2005-2006; 66(3):41-6. PubMed ID: 17252741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and genetic study of a case with Smith-Magenis syndrome].
    Shen LX; Zhang JS; Ji X; Xing Y; Hu J; Tao J; Xiao B
    Zhonghua Er Ke Za Zhi; 2012 Mar; 50(3):227-30. PubMed ID: 22801211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microdeletion on 17p11.2 in a Smith-Magenis syndrome patient with mental retardation and congenital heart defect: first report from China.
    Huang C; Yang YF; Zhang H; Xie L; Chen JL; Wang J; Tan ZP; Luo H
    Genet Mol Res; 2012 Aug; 11(3):2321-7. PubMed ID: 22911601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive functioning in children and adults with Smith-Magenis syndrome.
    Osório A; Cruz R; Sampaio A; Garayzábal E; Carracedo A; Fernández-Prieto M
    Eur J Med Genet; 2012 Jun; 55(6-7):394-9. PubMed ID: 22579991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral disturbance and treatment strategies in Smith-Magenis syndrome.
    Poisson A; Nicolas A; Cochat P; Sanlaville D; Rigard C; de Leersnyder H; Franco P; Des Portes V; Edery P; Demily C
    Orphanet J Rare Dis; 2015 Sep; 10():111. PubMed ID: 26336863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of welfare reform on SSA's disability programs: design of policy evaluation and early evidence.
    Davies P; Iams H; Rupp K
    Soc Secur Bull; 2000; 63(1):3-11. PubMed ID: 10951686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First in line: prioritizing receipt of Social Security disability benefits based on likelihood of death during adjudication.
    Rasch EK; Huynh M; Ho PS; Heuser A; Houtenville A; Chan L
    Med Care; 2014 Nov; 52(11):944-50. PubMed ID: 25310524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Turkish patient with large 17p11.2 deletion presenting with Smith Magenis syndrome.
    Tug E; Cine N; Aydin H
    Genet Couns; 2011; 22(1):11-9. PubMed ID: 21614983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related changes in behavioural and emotional problems in Smith-Magenis syndrome measured with the Developmental Behavior Checklist.
    Nag HE; Nærland T
    J Intellect Disabil; 2021 Dec; 25(4):429-440. PubMed ID: 31984836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.